drugset / Trial / NCT02265965

Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension

NCT02265965

Phase 4 Completed 18 enrolled University of California, San Francisco
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.

Timeline

Start
2015-10
Primary completion
2018-07-01
Completion
2018-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown Intravenous

Indications

No indication recorded.